ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

34,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 273

$1.76M Total Retail Price of All Prescriptions

Rank: 2 out of 273

1,637 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

1% of this provider’s 1,637 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 30,791 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
PRAVASTATIN SODIUM 2,135 1,903 10 1 11
LISINOPRIL 1,847 1,675 2 4
AMLODIPINE BESYLATE 1,717 1,568 3 2
FUROSEMIDE 1,700 1,549 4 5
METOPROLOL SUCCINATE 1,473 1,305 5 1
CRESTOR 1,360 1,199 6 14
ISOSORBIDE MONONITRATE ER 1,277 1,116 7 13
CARVEDILOL 1,188 1,025 8 3
SIMVASTATIN 1,093 980 9 6
WARFARIN SODIUM 1,014 916 10 7
POTASSIUM CHLORIDE 916 801 11 18
ATORVASTATIN CALCIUM 913 765 12 8
ATENOLOL 883 799 13 17
DIGOXIN 878 835 10 14 15
ZETIA 806 653 10 15 30
CLOPIDOGREL 748 584 16 9
DOXAZOSIN MESYLATE 696 651 17 55
FENOFIBRATE 627 509 18 34
PRADAXA 529 516 10 19 22
SOTALOL 473 446 20 27
BISOPROLOL FUMARATE 473 418 20 45
PLAVIX 457 360 22 12
OMEPRAZOLE 440 379 23 33
METOPROLOL TARTRATE 390 350 24 10
COUMADIN 366 362 25 50
DIOVAN 345 317 26 21
LOSARTAN POTASSIUM 322 289 27 19
AMIODARONE HCL 307 302 28 23
LEVOTHYROXINE SODIUM 303 292 29 25
CLONIDINE HCL 289 243 30 32
KLOR-CON M20 270 254 31 39
HYDROCHLOROTHIAZIDE 261 222 32 16
SPIRONOLACTONE 257 238 33 20
TRICOR 249 225 34 63
BENAZEPRIL HCL 239 224 35 35
AMLODIPINE BESYLATE-BENAZEPRIL 233 207 36 47
TRIAMTERENE-HCTZ 232 216 37 53
NIASPAN 232 199 37 51
CILOSTAZOL 230 205 39 56
LIPITOR 225 199 40 29
SERTRALINE HCL 198 158 41 81
METOLAZONE 185 169 42 94
BYSTOLIC 185 160 42 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 182 163 44 38
DILTIAZEM 24HR ER 177 120 45 49
NIFEDIPINE ER 176 160 46 43
TORSEMIDE 172 141 47 65
HYDRALAZINE HCL 167 152 48 36
DILTIAZEM ER 163 131 49 66
XARELTO 159 159 50 61
EXFORGE 150 139 51 82
PANTOPRAZOLE SODIUM 149 130 52 41
ENALAPRIL MALEATE 146 117 53 31
NITROSTAT 141 102 54 28
RAMIPRIL 139 118 55 24
TRANDOLAPRIL 120 113 56 109
NEXIUM 117 90 57 42
WELCHOL 111 92 58 118
COLESTIPOL HCL 110 110 59 145
MULTAQ 107 104 60 52
GEMFIBROZIL 105 83 61 83
BISOPROLOL-HYDROCHLOROTHIAZIDE 99 95 62 84
EFFIENT 94 90 63 67
LABETALOL HCL 94 73 63 100
RANEXA 91 39 65 37
SYNTHROID 90 81 66 90
PROPRANOLOL HCL 89 82 67 148
JANTOVEN 86 77 68 93
TRILIPIX 78 69 69 75
LOVASTATIN 77 77 70 44
BENICAR 71 58 71 88
LOVAZA 66 63 72 60
QUINAPRIL HCL 57 39 73 76
MICARDIS 53 53 74 140
DILTIAZEM 24HR CD 52 42 75 62
TIKOSYN 52 52 75 69
DIOVAN HCT 51 46 77 58
CITALOPRAM HBR 50 50 78 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.